Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02539342 · ClinicalTrials.gov registry record · Phase 3
Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy
A Phase 3 study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT02539342 is a Phase 3 study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 1 participants.
The verdict
NCT02539342, a Phase 3 study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.
Interventions
- DRUG Caphosol
- DRUG Biotene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-03-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02539342
The ClinicalTrials.gov registry entry for NCT02539342 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Caphosol is the first listed.
NCT02539342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02539342 about?
NCT02539342 is a clinical study titled "Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy". The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.
What is the current status of trial NCT02539342?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2016-10. Estimated completion is 2017-03-02.
What interventions are being tested in trial NCT02539342?
The interventions under investigation include: Caphosol (DRUG), Biotene (DRUG).
Who is sponsoring clinical trial NCT02539342?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.